In vivo and in vitro metabolic studies of furazolidone: a risk evaluation
- PMID: 2102448
- DOI: 10.3109/03602539008991460
In vivo and in vitro metabolic studies of furazolidone: a risk evaluation
Similar articles
-
The bioavailability of residues of the furazolidone metabolite 3-amino-2-oxazolidinone in porcine tissues and the effect of cooking upon residue concentrations.Food Addit Contam. 1997 Jul;14(5):507-13. doi: 10.1080/02652039709374558. Food Addit Contam. 1997. PMID: 9328536
-
Summary of bound residue chemistry session.Drug Metab Rev. 1990;22(6-8):677-80. doi: 10.3109/03602539008991461. Drug Metab Rev. 1990. PMID: 2102449 No abstract available.
-
[The residue behavior of the furazolidone metabolite 3-(4-cyano-2-oxobutylideneamino)-2-oxazolidone in trout].Z Lebensm Unters Forsch. 1990 Oct-Nov;191(4-5):319-21. doi: 10.1007/BF01202435. Z Lebensm Unters Forsch. 1990. PMID: 2293521 German.
-
Development of a unified approach to evaluate the toxicological potential of bound residues.Drug Metab Rev. 1990;22(6-8):891-904. doi: 10.3109/03602539008991477. Drug Metab Rev. 1990. PMID: 2102465 Review. No abstract available.
-
Potential use of isolated organ or tissue preparations in the assessment of biological activities of bound residues.Drug Metab Rev. 1990;22(6-8):753-63. doi: 10.3109/03602539008991466. Drug Metab Rev. 1990. PMID: 2102454 Review. No abstract available.
Cited by
-
Pharmacological, therapeutic and toxicological properties of furazolidone: some recent research.Vet Res Commun. 1999 Oct;23(6):343-60. doi: 10.1023/a:1006333608012. Vet Res Commun. 1999. PMID: 10543364 Review.
-
Presence of nitrofurans and their metabolites in gelatine.EFSA J. 2021 Oct 29;19(10):e06881. doi: 10.2903/j.efsa.2021.6881. eCollection 2021 Oct. EFSA J. 2021. PMID: 34745360 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources